23P Enriching for response: Patient selection criteria for A2AR inhibition by EXS-21546 through ex vivo modelling in primary patient material

G. Vladimer, I. Alt, R. Sehlke, A. Lobley, C. Baumgärtler, M. Stulic, K. Hackner, L. Dzurillova, E. Petru, L. Hadjari, J. Lafleur, J. Singer, N. Krall, J. Šufliarsky, L. Hefler, T. Fuereder, C. Taubert, C. Boudesco, A. Payne

Research output: Journal article (peer-reviewed)Conference contribution to journal

Original languageEnglish
Pages (from-to)100128
JournalImmuno-Oncology and Technology
Publication statusPublished - 01 Dec 2022

Cite this